Once-daily opioids for chronic dyspnea: A dose increment and pharmacovigilance study

Journal of Pain and Symptom Management

Volumn 42, Issue 3, 2011, Pages 388-399

  Currow, David C ^a   McDonald, Christine ^b   Oaten, Sheila ^a   Kenny, Bernadette ^a   Allcroft, Peter ^c   Frith, Peter ^c   Briffa, Michael ^d   Johnson, Miriam J ^e   Abernethy, Amy P ^a,f  

^a FLINDERS UNIVERSITY   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e UNIVERSITY OF HULL   (United Kingdom)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

clinical effectiveness; dyspnea; opioids; Palliative care; respiratory

Indexed keywords

LAXATIVE; MORPHINE;

ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTIPATION; CONTROLLED STUDY; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GENERAL CONDITION IMPROVEMENT; HOSPITALIZATION; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEOPLASM; PHASE 2 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; RESPIRATION DEPRESSION; SUSTAINED DRUG RELEASE; TREATMENT RESPONSE;

AGED; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DYSPNEA; FEMALE; HUMANS; MALE; MORPHINE; PHARMACOVIGILANCE; TREATMENT OUTCOME;

EID: 80051984765     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.11.021     Document Type: Article

References (32)

1. A.P. Abernethy, D.C. Currow, and P. Frith Randomised double-blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 525
2. D.C. Currow, J. Plummer, A. Crockett, and A.P. Abernethy A community population survey of prevalence and severity of dyspnea in adults J Pain Symptom Manage 38 2009 533 545
3. E. Hammond Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women Am J Public Health Nations Health 54 1964 11 23
4. D.C. Currow, J. Smith, and P.M. Davidson Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study J Pain Symptom Manage 39 2010 680 690
5. A.L. Jennings, A.N. Davies, J.P. Higgins, J.S.R. Gibbs, and K.E. Broadley A systematic review of the use of opioids in the management of dyspnoea Thorax 57 2002 939 944 (Pubitemid 35316271)
6. D.A. Mahler, J.A. Murray, and L.A. Waterman Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD Eur Respir J 33 2009 771 777
7. D.A. Mahler, P.A. Selecky, and C.G. Harrod American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease Chest 137 2010 674 691
8. P. Allard, C. Lamontagne, P. Bernard, and C. Tremblay How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial J Pain Symptom Manage 17 1999 256 265 (Pubitemid 29159968)
9. E. Bruera, T. MacEachern, C. Ripamonti, and J. Hanson Subcutaneous morphine for dyspnea in cancer patients Ann Intern Med 119 1993 906 907 (Pubitemid 23316875)
10. J.W. Berrill, and S.J. Linnasne Morphine for management of refractory dyspnoea: opiates should be used with caution BMJ 327 2003 1288
11. D.C. Currow, A.P. Abernethy, and P. Frith Morphine for management of refractory dyspnoea BMJ 327 2003 1288 1289
12. Anonymous Medical Research Council Committee on Aetiology of Chronic Bronchitis. Standardized questionnaires on respiratory symptoms BMJ 2 1960 1665
13. Anonymous. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2006. Available from http://www.goldcopd.org.
14. J.C. Bestall, E.A. Paul, and R. Garrod Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581 586 (Pubitemid 29296676)
15. A.P. Abernethy, T.M. Shelby-James, B.S. Fazekas, D. Woods, and D.C. Currow The Australian-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice BMC Palliat Care 4 2005 7
16. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
17. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
18. S.R. Cohen, B.M. Mount, M.G. Strobel, and F. Bui The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability Palliat Med 9 1995 207 219
19. E. von Elm, D.G. Altman, M. Egger STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies BMJ 335 2007 806 808 (Pubitemid 350057266)
20. D.S. Ander, I.P. Aisiku, J.J. Ratcliff, K.H. Todd, and K. Gotsch Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 10 2004 188 191
21. D.J. Karras, M.E. Sammon, and C.A. Terregino Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334 (Pubitemid 30207971)
22. A.L. Ries Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analogue Scale COPD 2 2005 105 110 (Pubitemid 40776230)
23. S. Booth Improving research methodology in breathlessness: a meeting convened by the MRC clinical trials unit and the Cicely Saunders Foundation Palliat Med 20 2006 219 220 (Pubitemid 43871342)
24. M.J. Johnson, T.A. McDonagh, A. Harkness, S.E. McKay, and H.J. Dargie Morphine for the relief of breathlessness in patients with chronic heart failure - A pilot study Eur J Heart Fail 4 2002 753 756 (Pubitemid 35403084)
25. A.P. Abernethy, C.F. McDonald, and P.A. Frith Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnea: a double-blind randomized controlled trial Lancet 376 2010 784 793
26. D.A. Mahler Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease Proc Am Thorac Soc 3 2006 234 238 (Pubitemid 43668187)
27. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
28. K.E. Clemens, and E. Klaschik Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients J Pain Symptom Manage 33 2007 473 481 (Pubitemid 46482946)
29. D.C. Currow, J. Plummer, P. Frith, and A.P. Abernethy Can we predict which patients with refractory dyspnea will respond to opioids? J Palliat Med 10 2007 1031 1036 (Pubitemid 350073568)
30. P.J. Poole, A.G. Veale, and P.N. Black The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 6 Pt 1 1998 1877 1880
31. D.E. O'Donnell, R.B. Banzett, and V. Carrieri-Kohlman Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable Proc Am Thorac Soc 4 2007 145 168 (Pubitemid 46743309)
32. L. Härmark, and A.C. van Grootheest Pharmacovigilance: methods, recent developments and future perspectives Eur J Clin Pharmacol 64 2008 743 752